Summary
Incubation of hexamethylmelamine for 1 h with human tumor cell lines in culture did not inhibit colony formation at concentrations up to the limit of drug solubility (200 μg/ml). When 1-h incubations were carried out in the presence of a 9,000 g rat liver supernatant preparation and an NADPH-generating system, hexamethylmelamine markedly reduced colony formation. Cyclophosphamide inhibition of colony formation was also dependent on the presence of a 9,000 g supernatant preparation and an NADPH-generating system in incubation mixtures. A 1-h incubation of N-methylolpentamethylmelamine (a DNA-alkylating metabolite formed during N-demethylation of hexamethylmelamine) with human tumor cell lines reduced colony formation in the absence of the liver-activating system. Substantial NADPH-dependent N-demthylation of hexamethylmelamine was observed with rat liver, lung, and kidney microsomal preparations. In contrast, little or no HMM metabolism was observed with tumor cells, tumor cell homogenates, or NADPH-fortified tumor cell microsomal preparations. NADPH-dependent formation of cytotoxic metabolites is a prerequisite for antiproliferative activity of hexamethymelamine against these human tumor cell lines. In vivo activity of hexamethylmelamine against some tumors may require metabolism by normal cells and subsequent transport of active species to the tumor site.
Similar content being viewed by others
References
Ames MM, Kovach JS (1982) Parenteral formulation of hexamethylmelamine potentially suitable for use in man. Cancer Treat Rep 66:1579
Ames MM, Powis G (1980) Metabolism of hexamethylmelamine and pentamethylmelamine by rat liver microsomes and isolated hepatocytes. Proc Am Assoc Cancer Res 21:257
Ames BN, McCann J, Yamasaki E (1975) Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat Res 31:347
Ames MM, Powis G, Kovach JS, Eagan RT (1979) Disposition and metabolism of pentamethylmelamine and hexamethylmelamine in rabbits and humans. Cancer Res 39:5016
Ames MM, Sanders ME, Tiede WS (1981) Metabolic activation of hexamethylmelamine and pentamethylmelamine by liver microsomal preparations. Life Sci 29:1591
Ames MM, Sanders ME, Tiede WS (1983) Role of N-methylopentamethylmelamine in the metabolic activation of hexamethylmelamine. Cancer Res 43:500
Begleiter A, Grover J, Goldenberg GJ (1980) Uptake and metabolism of hexamethylmelamine and pentamethylmelamine by L5178Y lymphoblasts in vitro. Cancer 40:4489
Blum RH, Livingston RB, Carter SK (1973) Hexamethylmelamine — a new drug with activity in solid tumors. Eur J Cancer 9:195
D'Incalci M, Bolis G, Mangioni C, Morasca L, Garattini S (1977) Regression of human lung tumor xenografts induced by water-soluble analogs of hexamethylmelamine. Cancer Treat Rep 61:927
Ernster L, Sickevitz, P, Palade GE (1962) Enzyme-structure relationships in the endoplasmic reticulum of rat liver. J Cell Biol 15:541
Garattini E, Donelli MG, Colombo T, Peasani R, Pantarotto C (1981) In vivo and in vitro irreversible binding of hexamethylmelamine to liver and ovarian tumor macromolecules of mice. Biochem Pharmacol 30:1151
Garner RC, Miller EC, Miller JA (1972) Liver microsomal metabolism of aflatoxin B, to a reactive derivative toxic to Salmonella typhimurium TA 1530. Cancer Res 32:2058
Gescher A, D'Incalci M, Fanelli R, Farina P (1980) N-Hydroxymethylpentamethylmelamine, a major in vitro metabolite of hexamethylmelamine. Life Sci 26:147
Grochow LB, Colvin M (1983) Clinical pharmacokinetics of cyclophosphamide. In: Ames MM, Powis G, Kovach JS (eds) Anticancer agents in humans Elsevier, New York 135
Kovach JS, Svingen PA (1984) Antiproliferative activity of 2-[N,N-bis-2-chloroethyl)-amino]4-[2-sulfonato-ethylthiol]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide cyclohexamine (AS-TAZ 7577) against human and murine tumor cells in vitro. Invest New Drugs 2:155
Legha SS, Slavik M, Carter SK (1976) Hexamethylmelamine — an evaluation of its role in the therapy of cancer. Cancer 38:27
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265
Rutty CJ, Abel G (1980) In vitro cytotoxicity of the melamines. Chem Biol Interact 29:235
Rutty CJ, Connors TA (1977) In vitro studies with hexamethylmelamine. Biochem Pharmacol 26:2385
Rutty CJ, Connors JA, Nguyen-Hoang-Dam DCT, Hoellinger H (1978) In vivo studies with hexamethylmelamine. Eur J Cancer 14:713
Sanders ME, Ames MM (1984) Synthesis of N-hydroxymethylpentamethylmelamine (ring 14C7, a cytotoxic metabolite of hexamethylmelamine. Journal of Radiolabeled Compounds and Radiopharmaceuticals. 21:893
Wolpert-DeFilippes MK (1979) Antitumor activity of cis-dichlorodiammine-platinum (II). Cancer Treat Rep 63:1453
Worzalla JF, Lee DM, Johnson RO, Bryan GT (1972) Effects of microsomal enzyme-inducing chemicals on the metabolism of Hexamethylmelamine (HMM, NSC-13875) in rats and hamsters. Proc Am Assoc Cancer Res 12:41
Worzalla JF, Kaiman BD, Johnson BM, Ramizrez G, Bryan GT (1974) Metabolism of hexamethylmelamine-ring-14C in rats and man. Cancer Res 34:2669
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Miller, K.J., McGovern, R.M. & Ames, M.M. Effect of a hepatic activation system on the antiproliferative activity of hexamethylmelamine against human tumor cell lines. Cancer Chemother. Pharmacol. 15, 49–53 (1985). https://doi.org/10.1007/BF00257294
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00257294